Dupixent Study for Alternate Administration

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
Investigators will investigate an alternate Dupilumab administration schedule in patients with recurrent chronic rhinosinusitis with nasal polyposis, who have a history of full endoscopic sinus surgery and are on appropriate topical medical therapies. Specifically, investigators will investigate if the alternate schedule of drug administration is non-inferior in both subjective and objective outcomes.
Epistemonikos ID: 1990a4806a274634dd170a086ce7edf7818b4d05
First added on: Mar 27, 2025